Please use this identifier to cite or link to this item: http://hdl.handle.net/1942/32696
Full metadata record
DC FieldValueLanguage
dc.contributor.authorHartung, H-P-
dc.contributor.authorComi, G.-
dc.contributor.authorArnold, D. L.-
dc.contributor.authorBoyko, A. N.-
dc.contributor.authorHavrdova, E. K.-
dc.contributor.authorInshasi, J. S.-
dc.contributor.authorMcCombe, P.-
dc.contributor.authorNakamura, K.-
dc.contributor.authorOreja-Guevara, C.-
dc.contributor.authorPelletier, D.-
dc.contributor.authorPozzilli, C.-
dc.contributor.authorSelmaj, K. W.-
dc.contributor.authorScott, T. F.-
dc.contributor.authorChung, L.-
dc.contributor.authorDaizadeh, N.-
dc.contributor.authorAfsar, S.-
dc.contributor.authorVAN WIJMEERSCH, Bart-
dc.date.accessioned2020-11-25T13:30:06Z-
dc.date.available2020-11-25T13:30:06Z-
dc.date.issued2020-
dc.date.submitted2020-11-05T10:50:19Z-
dc.identifier.citationMULTIPLE SCLEROSIS JOURNAL, 26 (9) , p. NP60 -NP61-
dc.identifier.urihttp://hdl.handle.net/1942/32696-
dc.description.sponsorshipPan Asian Comm Treatment & Res Multiple Sclerosis-
dc.language.isoen-
dc.publisherSAGE PUBLICATIONS LTD-
dc.titleAlemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study)-
dc.typeJournal Contribution-
local.bibliographicCitation.conferencedateNOV 13-15, 2019-
local.bibliographicCitation.conferencenameConference of the Pan-Asian-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis (PACTRIMS)-
local.bibliographicCitation.conferenceplaceSingapore, SINGAPORE-
dc.identifier.epageNP61-
dc.identifier.issue9-
dc.identifier.spageNP60-
dc.identifier.volume26-
local.format.pages2-
local.bibliographicCitation.jcatM-
local.publisher.place1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND-
local.type.refereedRefereed-
local.type.specifiedMeeting Abstract-
dc.identifier.isiWOS:000556862300071-
local.provider.typewosris-
local.uhasselt.uhpubyes-
local.description.affiliation[Hartung, H-P] Heinrich Heine Univ, Dept Neurol, Dusseldorf, Germany.-
local.description.affiliation[Comi, G.] Univ Vita Salute San Raffaele, Milan, Italy.-
local.description.affiliation[Arnold, D. L.] NeuroRx Res, Montreal, PQ, Canada.-
local.description.affiliation[Arnold, D. L.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.-
local.description.affiliation[Boyko, A. N.] Pirogov Russian Natl Res Univ, Moscow, Russia.-
local.description.affiliation[Boyko, A. N.] Usupov Hosp, Demyelinating Dis Ctr, Moscow, Russia.-
local.description.affiliation[Havrdova, E. K.] Charles Univ Prague, Med Fac 1, Prague, Czech Republic.-
local.description.affiliation[Inshasi, J. S.] Rashid Hosp, Dubai, U Arab Emirates.-
local.description.affiliation[Inshasi, J. S.] Dubai Med Coll, Dubai, U Arab Emirates.-
local.description.affiliation[McCombe, P.] Univ Queensland, Brisbane, Qld, Australia.-
local.description.affiliation[Nakamura, K.] Cleveland Clin, Cleveland, OH 44106 USA.-
local.description.affiliation[Oreja-Guevara, C.] Univ Hosp San Carlos, Madrid, Spain.-
local.description.affiliation[Pelletier, D.] Univ Southern Calif, Keck Sch Med, Los Angeles, CA 90007 USA.-
local.description.affiliation[Pozzilli, C.] Univ Rome, Rome, Italy.-
local.description.affiliation[Selmaj, K. W.] Univ Warmia & Mazury, Olsztyn, Poland.-
local.description.affiliation[Scott, T. F.] Allegheny Gen Hosp, Pittsburgh, PA 15212 USA.-
local.description.affiliation[Chung, L.; Daizadeh, N.; Afsar, S.] Sanofi, Cambridge, MA USA.-
local.description.affiliation[Van Wijmeersch, B.] Hasselt Univ, BIOMED, Rehabil & MS Ctr Overpelt, Hasselt, Belgium.-
item.fullcitationHartung, H-P; Comi, G.; Arnold, D. L.; Boyko, A. N.; Havrdova, E. K.; Inshasi, J. S.; McCombe, P.; Nakamura, K.; Oreja-Guevara, C.; Pelletier, D.; Pozzilli, C.; Selmaj, K. W.; Scott, T. F.; Chung, L.; Daizadeh, N.; Afsar, S. & VAN WIJMEERSCH, Bart (2020) Alemtuzumab Improves Clinical and MRI Disease Activity Outcomes, Including Slowing of Brain Volume Loss, in RRMS Patients Over 8 Years: CARE-MS I Follow-up (TOPAZ Study). In: MULTIPLE SCLEROSIS JOURNAL, 26 (9) , p. NP60 -NP61.-
item.contributorHartung, H-P-
item.contributorComi, G.-
item.contributorArnold, D. L.-
item.contributorBoyko, A. N.-
item.contributorHavrdova, E. K.-
item.contributorInshasi, J. S.-
item.contributorMcCombe, P.-
item.contributorNakamura, K.-
item.contributorOreja-Guevara, C.-
item.contributorPelletier, D.-
item.contributorPozzilli, C.-
item.contributorSelmaj, K. W.-
item.contributorScott, T. F.-
item.contributorChung, L.-
item.contributorDaizadeh, N.-
item.contributorAfsar, S.-
item.contributorVAN WIJMEERSCH, Bart-
item.accessRightsClosed Access-
item.fulltextNo Fulltext-
Appears in Collections:Research publications
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.